{"schema_version":"secwatch.filing_event.v1","accession":"0001815849-24-000035","form_type":"8-K","ticker":null,"cik":"0001815849","company_name":"ATI Physical Therapy, Inc.","filed_at":"2024-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.303519+00:00","generated_at":"2026-06-02T22:19:13.975715+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ATI Physical Therapy Q1 revenue $181.5M (+8.7% YoY); Q2 guidance $185-195M","bullets":["Net revenue $181.5M, up 8.7% vs Q1 2023; net patient revenue $165.4M (+9.7%).","Visits per Day 23,837 (+5.0%) driven by increased clinical FTE capacity.","Clinician turnover rate improved to 16% as part of culture and retention efforts.","Q2 2024 guidance: revenue $185-195M, Adjusted EBITDA $15-20M.","Other revenue flat at $16.1M vs $16.2M in prior year."],"urls":{"canonical":"https://secwatch.observer/filing/0001815849-24-000035","json":"https://secwatch.observer/filing/0001815849-24-000035.json","markdown":"https://secwatch.observer/filing/0001815849-24-000035.md","text":"https://secwatch.observer/filing/0001815849-24-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815849/000181584924000035/0001815849-24-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815849/000181584924000035/ati-20240506.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T22:19:13.975715+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b393ae5643bdfc5146dc1afd1a8a055a5026a764","claim":"ATI Physical Therapy, Inc. reported the first quarter ended March 31, 2024 results: revenue $181.5 million. Guidance reaffirmed.","evidence_excerpt":"are presented after the financial statements at the end of this press release. Commentary on performance results in the first quarter of 2024 is as follows: • Net revenue was $181.5 million compared to $166.9 million in the first quarter of 2023, an increase of 8.7%. ▪ Net patient revenue was $165.4 million compared to $150.8 million in the first quarter of 2023, an","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815849/000181584924000035/0001815849-24-000035-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Revenue","value":"$181.5 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}